Jazz Pharmaceuticals plc Long-Term Debt
Jazz Pharmaceuticals plc (JAZZ) had Long-Term Debt of $3.33 billion as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:LongTermDebtNoncurrent · last filed 2026-08-03
- 2026-06-30: Long-term Debt, Excluding Current Maturities $3.33B.
- 2026-03-31: Long-term Debt, Excluding Current Maturities $4.32B.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $4.33B; Long-term Debt, Excluding Current Maturities as first filed $4.33B.
- 2025-09-30: Long-term Debt, Excluding Current Maturities $4.33B.
| Period end | Long-term Debt, Excluding Current Maturities | Long-term Debt, Excluding Current Maturities as first filed |
|---|---|---|
| 2026-06-30 | $3.33B 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $4.32B 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $4.33B 10-Q · filed 2026-08-03 | $4.33B 10-K · filed 2026-02-24 |
| 2025-09-30 | $4.33B 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $4.34B 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $5.34B 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $6.08B 10-K · filed 2026-02-24 | |
| 2024-09-30 | $6.08B 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $5.10B 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $5.11B 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $5.11B 10-K · filed 2025-02-26 | |
| 2023-09-30 | $5.11B 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $5.69B 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $5.69B 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $5.69B 10-K · filed 2024-02-28 | |
| 2022-09-30 | $5.70B 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $5.99B 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $5.99B 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $6.02B 10-K · filed 2023-03-01 | |
| 2021-09-30 | $6.25B 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $6.49B 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $1.85B 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $1.85B 10-K · filed 2022-03-01 | |
| 2020-09-30 | $1.84B 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $2.07B 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $1.58B 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $1.57B 10-K · filed 2021-02-23 | |
| 2019-09-30 | $1.57B 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $1.57B 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $1.57B 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $1.56B 10-K · filed 2020-02-25 | |
| 2018-09-30 | $1.56B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $1.56B 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $1.54B 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $1.54B 10-K · filed 2019-02-26 | |
| 2017-09-30 | $1.54B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $1.64B 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $1.74B 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $1.99B 10-K · filed 2018-02-27 | |
| 2016-09-30 | $2.15B 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $1.14B 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $1.15B 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $1.15B 10-K · filed 2017-02-28 | $1.17B 10-K · filed 2016-02-23 |
| 2015-09-30 | $1.17B 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $1.34B 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $1.33B 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $1.33B 10-K · filed 2016-02-23 | |
| 2014-09-30 | $1.33B 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $1.19B 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $1.19B 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $544.40M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $545.56M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $546.72M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $418.51M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $427.07M 10-K · filed 2014-02-25 | |
| 2012-09-30 | $435.63M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $444.19M 10-Q · filed 2012-08-07 | |
| 2011-12-31 | $0.00 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |